A Randomized Clinical Trial of Glyburide (RP-1127) for TBI

Trial Profile

A Randomized Clinical Trial of Glyburide (RP-1127) for TBI

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 04 May 2017

At a glance

  • Drugs Glibenclamide (Primary)
  • Indications Brain injuries
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms INTRuST-GLY
  • Sponsors Remedy Pharmaceuticals
  • Most Recent Events

    • 05 May 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 31 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top